NCT00591266 - Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension | Biotech Hunter

Enrollment

566

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions

Hypertension

Interventions

DRUG

Azilsartan Medoxomil and amlodipine

Azilsartan Medoxomil 40 mg, tablets, orally, once daily and amlodipine 5 mg, tablets, orally, once daily for up to 6 weeks.

DRUG

Azilsartan Medoxomil and amlodipine

Azilsartan Medoxomil 80 mg, tablets, orally, once daily and amlodipine 5 mg, tablets, orally, once daily for up to 6 weeks.

DRUG

Amlodipine

Azilsartan medoxomil placebo-matching tablets, orally, once daily and amlodipine 5 mg, tablets, orally, once daily for up to 6 weeks.

Trial Locations (50)

Unknown

Mesa

Phoenix

Anaheim

Beverly Hills

Burbank

Burlingame

La Jolla

Orange

Roseville

Tustin

Wheat Ridge

Newark

Washington D.C.

Hialeah

Longwood

Tampa

Honolulu

Boise

Chicago

Gurnee

Peoria

Elkhart

Crestview Hills

Lexington

Riverdale

Brockton

Haverhill

North Dartmouth

Kansas City

Omaha

Raleigh

Akron

Canton

Cincinnati

Mogadore

Norman

Tulsa

Warminster

Cumberland

Arlington

Austin

Carrollton

Dallas

Houston

Irvine

Lake Jackson

North Richland Hills

Manassas

Renton

Menomonee Falls